Publication: 3326

Publication: 3326

Genomic analysis of germline variation associated with survival of colorectal cancer patients treated with chemotherapy plus biologics in CALGB/SWOG 80405 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Clin Cancer Res vol 27 (1) 267-275

Year:: 2021
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: Yes
Book Volume:: 10

Parents:: 2280 2376
Children:: None

Program:: TRP
Primary Committee:: PPP
Sec. Committees:

Pharmas:: Bristol Myers Squibb (BMS), Genentech, Pfizer, and Sanofi
Grants:: U10CA180821, U10CA180882, U24CA196171, UG1CA233253, UG1CA233327, UG1CA233373, U10CA180888(SWOG)

Corr. Author:
Authors:: Federico Innocenti Alexander B. Sibley Sushant A. Patil Amy S. Etheridge Chen Jiang Fang-Shu Ou Stefanie D. Howell Sarah J Plummer Graham Casey Monica M. Bertagnolli Howard L. McLeod James T. Auman Charles D. Blanke Yoichi Furukawa Alan P. Venook Michiaki Kubo Heinz-Josef Lenz Joel S. Parker Mark J. Ratain Kouros Owzar

Networks:: CA011, CA824, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NC007, OR013

Study: CALGB-80405
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: CALGB/SWOG 80405, GWAS, overall survival, AXIN1